Prescription drug · ANDA
Furosemide NDC 70121-1164
Furosemide 40 mg/4mL · Injection · Intramuscular, Intravenous · Amneal Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70121-1164-5 | 70121116405 | 25 VIAL, GLASS in 1 CARTON (70121-1164-5) / 4 mL in 1 VIAL, GLASS (70121-1164-1)Marketed from Jul 25, 2016 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Furosemide
- Generic name (nonproprietary)
- furosemide
- Active ingredients
- Furosemide — 40 mg/4mL
- Dosage form
- Injection
- Route
- Intramuscular, Intravenous
- Labeler
- Amneal Pharmaceuticals LLCNDC labeler code 70121
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207552
- Marketing start
- Listing expires
- Other FDA classes
- Increased Diuresis at Loop of Henle (Physiologic effect)
- Identifiers
- Product ID 70121-1164_6c2c75db-4cb1-4cbc-8b98-2405d9fd4d21SPL ID 6c2c75db-4cb1-4cbc-8b98-2405d9fd4d21
- Pharmacologic class
- Loop Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470121116405followed by a unit qualifier and the quantityPackage 70121-1164-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 70121-1164
- What is NDC 70121-1164?
- 70121-1164 is the product NDC for Furosemide, Furosemide 40 mg/4mL injection, listed with the FDA by Amneal Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Furosemide.
- What is the active ingredient?
- Furosemide.
- Who is the labeler?
- Amneal Pharmaceuticals LLC, NDC labeler code 70121. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Furosemide?
- 211 other product NDCs are listed under this name. See all Furosemide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Furosemide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | Civica, Inc. | 72572-275 | 72572-0275-10 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-033 | 87441-0033-01 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4679 | 70518-4679-00 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Coupler LLC | 67046-0768 | 67046-0768-03 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4609 | 70518-4609-00 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | Coupler LLC | 67046-1663 | 67046-1663-03 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-832 | 10135-0832-0110135-0832-1010135-0832-90 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-833 | 10135-0833-0110135-0833-1010135-0833-90 |
| Furosemide | Furosemide 80 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-834 | 10135-0834-0110135-0834-0510135-0834-90 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Granulation Technology, Inc. | 63561-0164 | 63561-0164-0163561-0164-0263561-0164-09 |
Other NDCs under ANDA 207552
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Furosemide | Furosemide 20 mg/2mL | InjectionIntramuscular, Intravenous | Amneal Pharmaceuticals LLC | 70121-1163 |